NRSN

NEUROSENSE THERAPEUTICS LTD

NRSN·M74240108·US·Common Stock·Healthcare - Biotechnology

NRSN (NEUROSENSE THERAPEUTICS LTD) is held by 9 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($78,218), COMMONWEALTH EQUITY SERVICES, LLC ($16,400), PNC FINANCIAL SERVICES GROUP, INC. ($15,228). Net institutional sentiment: Mixed.

9
Holders
(3 Elite)
$157,405
Total Value
50% (6)
Consensus
3 buying - 3 selling
13F: Insider & Congress: Updated regularly
NRSN

Smart Money Verdict

View all
Loading verdict
Held by 9 funds
3 elite

Who's Trading

Source dates: Price Oct 9, 2026 · Insiders Apr 1, 2026 · Activists none · Congress none

InsiderBHBinder HagitVest 200K shMar 26, 2026
InsiderEOEisenberg OrVest 200K shMar 26, 2026
InsiderRNRussek-Blum NivaVest 200K shMar 26, 2026

Top Holders

Checking access…
Action
Increased
108,636(+121.3%)$78,2180.0%+347.50%
23
Unchanged
22,775$16,4000.0%+170.56%
0
Unchanged
21,150$15,2280.0%+321.18%
0
Unchanged
16,528$11,9000.0%+404.23%
0
Unchanged
15,870$11,4260.0%+297.42%
0
New
11,473$8,2610.0%+397.22%
23
Decreased
11,410(-4.2%)$8,2150.0%+404.23%
0
New
10,515$7,0000.0%+397.22%
25
Unchanged
1,000$7570.0%+88.42%
0
Exited
0(-100.0%)$21,6460.0%-15.29%
0
Exited
0(-100.0%)$33,5560.0%-22.66%
0
NRSNNRSNNEUROSENSE THERAPEUTICS LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used